Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories
Zwerwer LR. et al, (2025), Nature Communications, 16
Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients.
Poolchanuan P. et al, (2025), Scientific reports, 15
Publisher Correction: The molecular reach of antibodies crucially underpins their viral neutralisation capacity
Huhn A. et al, (2025), Nature Communications, 16
Engineering Genome-Free Bacterial Cells for Effective SARS-COV-2 Neutralisation.
Yin Y. et al, (2025), Microbial biotechnology, 18
The molecular reach of antibodies crucially underpins their viral neutralisation capacity
Huhn A. et al, (2025), Nature Communications, 16
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.
Duyvesteyn HME. et al, (2024), Structure (London, England : 1993), 32, 1594 - 1602.e6
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam
Thanh TT. et al, (2024), International Journal of Infectious Diseases, 147, 107173 - 107173
AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults.
Cai Y. et al, (2024), Sci Transl Med, 16
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Pouwels KB. et al, (2024), Nature Communications, 15
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
Liu C. et al, (2024), Cell Reports Medicine, 5, 101553 - 101553
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays.
Mühlemann B. et al, (2024), Science translational medicine, 16
The alteration of NK cells phenotypes related to the functions and dengue disease outcomes.
Taechasan N. et al, (2024), Virus research, 345
Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium
Nhu LNT. et al, (2024), Wellcome Open Research, 9, 181 - 181
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.
Liu C. et al, (2024), Nature communications, 15
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.
Zhou D. et al, (2024), Nature communications, 15
Emerging Enterovirus A71 Subgenogroup B5 Causing Severe Hand, Foot, and Mouth Disease, Vietnam, 2023
Chau NVV. et al, (2024), Emerging Infectious Diseases, 30
Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium.
Nhu LNT. et al, (2024), Wellcome open research, 9
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history
Hornsby H. et al, (2023), Nature Communications, 14